104 results
8-K
EX-4.3
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
8-K
EX-4.2
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
f
8-K
EX-4.1
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
8-K
EX-4.1
txkz6 7uqnjlaj4fz
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K/A
EX-10.1
k0j5oy
22 Aug 23
Departure of Directors or Certain Officers
8:30am
S-8
EX-99.1
ixgbi lpxomuivbaxu
9 Jun 23
Registration of securities for employees
5:19pm
8-K
EX-4.3
5vic3 z74asn
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.8
ag67f3yrh5ojr7ua
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.9
i8aqbk91ba56ldp
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.1
2ecl5j02qe
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.4
ajaibx
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-4.2
qpt833a f216
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm